Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns

Scott Denne, C. A. Karn, J. Wang, E. A. Liechty

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

To determine whether nonprotein substrate can suppress proteolysis in normal newborns and to assess the effect of this substrate on glucose production, the rates of appearance (R(a)) of leucine (reflecting proteolysis) and glucose were measured in healthy 2-day-old full-term newborns during fasting, an intravenous glucose infusion (5.5 mg · kg-1 · min-1), an intravenous lipid infusion (2.5 mg · kg-1 · min-1), and a combined glucose plus lipid infusion (5.5 mg · kg-1 · min-1 glucose + 2.5 mg · kg-1 · min-1 lipid). Leucine R(a) was not reduced from fasting values during any of the substrate infusions. Intravenous lipid infusion alone neither suppressed nor increased glucose production. In contrast, glucose production was nearly completely suppressed (~ 90%) during intravenous infusions of glucose provided either alone or in combination with lipid; this suppression was achieved at glucose concentrations of ~ 90 mg/dl and insulin concentrations of ~6 μU/ml. Thus normal newborns respond to intravenous glucose with sustained nearly complete suppression of glucose production, even at moderate levels of glycemia and at low insulin concentrations; however, nonprotein substrate infusion does not result in suppression of proteolysis. It remains unclear to what extent any potential regulator can suppress proteolysis in this population.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume269
Issue number2 32-2
StatePublished - 1995

Fingerprint

Proteolysis
proteolysis
neonates
Lipids
Glucose
glucose
lipids
Intravenous Infusions
Substrates
Leucine
leucine
fasting
Fasting
insulin
Insulin
blood glucose

Keywords

  • leucine
  • protein turnover
  • stable isotope tracers

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Agricultural and Biological Sciences(all)

Cite this

Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns. / Denne, Scott; Karn, C. A.; Wang, J.; Liechty, E. A.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 269, No. 2 32-2, 1995.

Research output: Contribution to journalArticle

@article{156df205a7be4129b44ca0d72351320f,
title = "Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns",
abstract = "To determine whether nonprotein substrate can suppress proteolysis in normal newborns and to assess the effect of this substrate on glucose production, the rates of appearance (R(a)) of leucine (reflecting proteolysis) and glucose were measured in healthy 2-day-old full-term newborns during fasting, an intravenous glucose infusion (5.5 mg · kg-1 · min-1), an intravenous lipid infusion (2.5 mg · kg-1 · min-1), and a combined glucose plus lipid infusion (5.5 mg · kg-1 · min-1 glucose + 2.5 mg · kg-1 · min-1 lipid). Leucine R(a) was not reduced from fasting values during any of the substrate infusions. Intravenous lipid infusion alone neither suppressed nor increased glucose production. In contrast, glucose production was nearly completely suppressed (~ 90{\%}) during intravenous infusions of glucose provided either alone or in combination with lipid; this suppression was achieved at glucose concentrations of ~ 90 mg/dl and insulin concentrations of ~6 μU/ml. Thus normal newborns respond to intravenous glucose with sustained nearly complete suppression of glucose production, even at moderate levels of glycemia and at low insulin concentrations; however, nonprotein substrate infusion does not result in suppression of proteolysis. It remains unclear to what extent any potential regulator can suppress proteolysis in this population.",
keywords = "leucine, protein turnover, stable isotope tracers",
author = "Scott Denne and Karn, {C. A.} and J. Wang and Liechty, {E. A.}",
year = "1995",
language = "English",
volume = "269",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "2 32-2",

}

TY - JOUR

T1 - Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns

AU - Denne, Scott

AU - Karn, C. A.

AU - Wang, J.

AU - Liechty, E. A.

PY - 1995

Y1 - 1995

N2 - To determine whether nonprotein substrate can suppress proteolysis in normal newborns and to assess the effect of this substrate on glucose production, the rates of appearance (R(a)) of leucine (reflecting proteolysis) and glucose were measured in healthy 2-day-old full-term newborns during fasting, an intravenous glucose infusion (5.5 mg · kg-1 · min-1), an intravenous lipid infusion (2.5 mg · kg-1 · min-1), and a combined glucose plus lipid infusion (5.5 mg · kg-1 · min-1 glucose + 2.5 mg · kg-1 · min-1 lipid). Leucine R(a) was not reduced from fasting values during any of the substrate infusions. Intravenous lipid infusion alone neither suppressed nor increased glucose production. In contrast, glucose production was nearly completely suppressed (~ 90%) during intravenous infusions of glucose provided either alone or in combination with lipid; this suppression was achieved at glucose concentrations of ~ 90 mg/dl and insulin concentrations of ~6 μU/ml. Thus normal newborns respond to intravenous glucose with sustained nearly complete suppression of glucose production, even at moderate levels of glycemia and at low insulin concentrations; however, nonprotein substrate infusion does not result in suppression of proteolysis. It remains unclear to what extent any potential regulator can suppress proteolysis in this population.

AB - To determine whether nonprotein substrate can suppress proteolysis in normal newborns and to assess the effect of this substrate on glucose production, the rates of appearance (R(a)) of leucine (reflecting proteolysis) and glucose were measured in healthy 2-day-old full-term newborns during fasting, an intravenous glucose infusion (5.5 mg · kg-1 · min-1), an intravenous lipid infusion (2.5 mg · kg-1 · min-1), and a combined glucose plus lipid infusion (5.5 mg · kg-1 · min-1 glucose + 2.5 mg · kg-1 · min-1 lipid). Leucine R(a) was not reduced from fasting values during any of the substrate infusions. Intravenous lipid infusion alone neither suppressed nor increased glucose production. In contrast, glucose production was nearly completely suppressed (~ 90%) during intravenous infusions of glucose provided either alone or in combination with lipid; this suppression was achieved at glucose concentrations of ~ 90 mg/dl and insulin concentrations of ~6 μU/ml. Thus normal newborns respond to intravenous glucose with sustained nearly complete suppression of glucose production, even at moderate levels of glycemia and at low insulin concentrations; however, nonprotein substrate infusion does not result in suppression of proteolysis. It remains unclear to what extent any potential regulator can suppress proteolysis in this population.

KW - leucine

KW - protein turnover

KW - stable isotope tracers

UR - http://www.scopus.com/inward/record.url?scp=0028878914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028878914&partnerID=8YFLogxK

M3 - Article

C2 - 7653553

AN - SCOPUS:0028878914

VL - 269

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 2 32-2

ER -